The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-7 of 7 articles
A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting stent: the ROLEX study
Tarantini G,
Nai Fovino L,
Varbella F,
Trabattoni D,
Caramanno G,
Trani C,
De Cesare N,
Esposito G,
Montorfano M,
Musto C,
Picchi A,
Sheiban I,
Gasparetto V,
Ribichini F,
Cardaioli F,
Saccà S,
Cerrato E,
Napodano M,
Martinato M,
Azzolina D,
Andò G,
Mugnolo A,
Caruso M,
Rossini R,
Passamonti E,
Teles RC,
Rigattieri S,
Gregori D,
Tamburino C,
Burzotta F
February 6, 2023 | 10.4244/EIJ-D-22-00454
Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended Registry
Schnorbus B,
Wiebe J,
Capodanno D,
Brugaletta S,
Geraci S,
Mehilli J,
Latib A,
Lesiak M,
Jensen C,
Mattesini A,
Munzel T,
Capranzano P,
Di Mario C,
Naber C,
Araszkiewicz A,
Colombo A,
Caramanno G,
Sabaté M,
Tamburino C,
Nef H,
Gori T
October 11, 2017 | 10.4244/EIJ-D-16-00568
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score
Ortega-Paz L,
Capodanno D,
Gori T,
Nef H,
Latib A,
Caramanno G,
Di Mario C,
Naber C,
Lesiak M,
Capranzano P,
Wiebe J,
Mehilli J,
Araszkiewicz A,
Pyxaras S,
Mattesini A,
Geraci S,
Naganuma T,
Colombo A,
Munzel T,
Sabaté M,
Tamburino C,
Brugaletta S
April 20, 2017 | 10.4244/EIJ-D-16-00974
Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registry
Gori T,
Wiebe J,
Capodanno D,
Latib A,
Lesiak M,
Pyxaras S,
Mehilli J,
Caramanno G,
Di Mario C,
Brugaletta S,
Weber J,
Capranzano P,
Sabaté M,
Mattesini A,
Geraci S,
Naber C,
Araszkiewicz A,
Colombo A,
Tamburino C,
Nef H,
Munzel T
August 5, 2016 | 10.4244/EIJY15M09_10
Hybrid strategy with a bioresorbable scaffold and a drug-coated balloon for diffuse coronary artery disease: the “no more metallic cages” multicentre pilot experience
Ielasi A,
Miyazaki T,
Geraci S,
Testa L,
Abdel-Wahab M,
Kawamoto H,
Ruparelia N,
Sato T,
Caramanno G,
Bedogni F,
Tespili M,
Colombo A,
Latib A
April 8, 2016 | 10.4244/EIJV11I14A309
Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective
Tamburino C,
Latib A,
van Geuns R,
Sabaté M,
Mehilli J,
Gori T,
Achenbach S,
Alvarez M,
Nef H,
Lesiak M,
Di Mario C,
Colombo A,
Naber C,
Caramanno G,
Capranzano P,
Brugaletta S,
Geraci S,
Araszkiewicz A,
Mattesini A,
Pyxaras S,
Rzeszutko L,
Depukat R,
Diletti R,
Boone E,
Capodanno D,
Dudek D
May 19, 2015 | 10.4244/EIJY15M01_05
Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry
Capodanno D,
Gori T,
Nef H,
Latib A,
Mehilli J,
Lesiak M,
Caramanno G,
Naber C,
Di Mario C,
Colombo A,
Capranzano P,
Wiebe J,
Araszkiewicz A,
Geraci S,
Pyxaras S,
Mattesini A,
Naganuma T,
Munzel T,
Tamburino C
February 20, 2015 | 10.4244/EIJY14M07_11
Latest news
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
PCR London Valves 2023
November 16, 2023
NEW ISSUE
PCR London Valves special edition. State-of-the-art on TMVI; the timing of TMVI; direct wire pacing for TMVR; predicting patient-prosthesis mismatch following TAVI and more
November 17, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
AHEAD OF PRINT
Cardiac damage classification in each AS subtype
FREE ARTICLE - Masaaki Nakase et al
November 6, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023
AHEAD OF PRINT
CAPTIS embolic protection during TAVR
FREE ARTICLE - Haim D. Danenberg et al
November 2, 2023